Dupont Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,289
| Closed | -$156K | – | 1685 |
|
|
2022
Q2 | $156K | Hold |
14,289
| – | – | 0.01% | 1051 |
|
|
2022
Q1 | $162K | Sell |
14,289
-1,264
| -8% | -$14.3K | 0.01% | 1143 |
|
|
2021
Q4 | $244K | Sell |
15,553
-6,201
| -29% | -$97.3K | 0.01% | 1052 |
|
|
2021
Q3 | $373K | Sell |
21,754
-26,915
| -55% | -$461K | 0.01% | 1006 |
|
|
2021
Q2 | $1.05M | Hold |
48,669
| – | – | 0.02% | 560 |
|
|
2021
Q1 | $731K | Sell |
48,669
-9,982
| -17% | -$150K | 0.02% | 735 |
|
|
2020
Q4 | $771K | Buy |
+58,651
| New | +$771K | 0.02% | 669 |
|
|
2020
Q1 | – | Sell |
-24,896
| Closed | -$409K | – | 1383 |
|
|
2019
Q4 | $409K | Hold |
24,896
| – | – | 0.01% | 931 |
|
|
2019
Q3 | $331K | Buy |
+24,896
| New | +$331K | 0.01% | 957 |
|
|
2019
Q2 | – | Sell |
-28,171
| Closed | -$518K | – | 1272 |
|
|
2019
Q1 | $518K | Sell |
28,171
-16,996
| -38% | -$313K | 0.01% | 744 |
|
|
2018
Q4 | $1.18M | Hold |
45,167
| – | – | 0.03% | 490 |
|
|
2018
Q3 | $1.04M | Hold |
45,167
| – | – | 0.02% | 557 |
|
|
2018
Q2 | $860K | Hold |
45,167
| – | – | 0.02% | 590 |
|
|
2018
Q1 | $761K | Sell |
45,167
-28,703
| -39% | -$484K | 0.02% | 587 |
|
|
2017
Q4 | $1.12M | Hold |
73,870
| – | – | 0.03% | 494 |
|
|
2017
Q3 | $1.32M | Buy |
+73,870
| New | +$1.32M | 0.03% | 462 |
|